Regulus Therapeutics Statistics

Total Valuation

RGLS has a market cap or net worth of $148.61 million. The enterprise value is $127.17 million.

Market Cap	148.61M
Enterprise Value	127.17M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, after market close.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

RGLS has 65.47 million shares outstanding. The number of shares has increased by 24.25% in one year.

Shares Outstanding	65.47M
Shares Change (YoY)	+24.25%
Shares Change (QoQ)	+3.09%
Owned by Insiders (%)	1.68%
Owned by Institutions (%)	76.73%
Float	41.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.01
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.31, with a Debt / Equity ratio of 0.11.

Current Ratio	3.31
Quick Ratio	n/a
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-48.73

Financial Efficiency

Return on equity (ROE) is -109.20% and return on invested capital (ROIC) is -131.95%.

Return on Equity (ROE)	-109.20%
Return on Assets (ROA)	-80.60%
Return on Capital (ROIC)	-131.95%
Revenue Per Employee	n/a
Profits Per Employee	-$1.00M
Employee Count	30
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, RGLS has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.91% in the last 52 weeks. The beta is 1.55, so RGLS's price volatility has been higher than the market average.

Beta (1Y)	1.55
52-Week Price Change	+66.91%
50-Day Moving Average	2.16
200-Day Moving Average	1.57
Relative Strength Index (RSI)	45.57
Average Volume (30 Days)	3,115,650

Short Selling Information

The latest short interest is 6.27 million, so 9.59% of the outstanding shares have been sold short.

Short Interest	6.27M
Short Previous Month	5.42M
Short % of Shares Out	9.59%
Short % of Float	15.10%
Short Ratio (days to cover)	9.44

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-31.11M
Pretax Income	-30.04M
Net Income	-30.04M
EBITDA	-29.21M
EBIT	-29.43M
Earnings Per Share (EPS)	-$1.58

Full Income Statement

Balance Sheet

The company has $23.83 million in cash and $2.39 million in debt, giving a net cash position of $21.44 million or $0.33 per share.

Cash & Cash Equivalents	23.83M
Total Debt	2.39M
Net Cash	21.44M
Net Cash Per Share	$0.33
Equity / Book Value	21.19M
Book Value Per Share	0.32
Working Capital	19.67M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$26.77 million and capital expenditures -$610,000, giving a free cash flow of -$27.38 million.

Operating Cash Flow	-26.77M
Capital Expenditures	-610,000
Free Cash Flow	-27.38M
FCF Per Share	-$1.44

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RGLS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.25%
Shareholder Yield	-24.25%
Earnings Yield	-20.21%
FCF Yield	-18.42%

Analyst Forecast

The average price target for RGLS is $7.25, which is 219.38% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.25
Price Target Difference	219.38%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 29, 2022. It was a reverse split with a ratio of 1:10.

Last Split Date	Jun 29, 2022
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	2